GESTIÓN EN SALUD PÚBLICA: AHRQ Patient Safety Network ► Meaningful Use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes.

sábado, 23 de mayo de 2015

AHRQ Patient Safety Network ► Meaningful Use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes.

AHRQ Patient Safety Network

PSNet header image

Meaningful Use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes.

Powers C, Gabriel MH, Encinosa W, Mostashari F, Bynum J. J Am Med Inform Assoc. 2015 May 6; [Epub ahead of print].

This analysis of Medicare data found that outpatient practices using electronic prescribing had fewer adverse drug events among their panel of patients with diabetes compared to practices not consistently using electronic prescribing. Although promising, this study does not address the many differences between practices that use electronic prescribing versus those that do not and the patients that select these disparate health care systems.

PubMed citation